{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/ABOS/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-16T18:11:07.323Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":3894,"canonical_name":"Acumen Pharmaceuticals, Inc.","cik":"0001576885","uei":null,"lei":null,"duns":null,"ticker":"ABOS"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":42},"count":42,"timeline":[{"ts":"2026-09-16","kind":"sec.filing","form_type":"8-K","title":"8-K — Acumen Pharmaceuticals, Inc. — 2026-09-16","url_slug":"/sec/cik-0001576885/8-k/0001628280-26-062137","accession_number":"0001628280-26-062137","importance":35},{"ts":"2026-08-12","kind":"sec.filing","form_type":"10-Q","title":"10-Q — Acumen Pharmaceuticals, Inc. — 2026-08-12","url_slug":"/sec/cik-0001576885/10-q/0001628280-26-056199","accession_number":"0001628280-26-056199","importance":45},{"ts":"2026-08-12","kind":"sec.filing","form_type":"8-K","title":"8-K — Acumen Pharmaceuticals, Inc. — 2026-08-12","url_slug":"/sec/cik-0001576885/8-k/0001628280-26-055940","accession_number":"0001628280-26-055940","importance":35},{"ts":"2026-08-12","kind":"sec.filing","form_type":"S-8","title":"S-8 — Acumen Pharmaceuticals, Inc. — 2026-08-12","url_slug":"/sec/cik-0001576885/s-8/0001628280-26-056240","accession_number":"0001628280-26-056240","importance":30},{"ts":"2026-06-17","kind":"sec.form144","reporter":"DERRELL PORTER","title":"Director","shares":13040,"usd_value":30323,"security_title":"Common","approx_sale_date":"2026-06-17","accession_number":"0001950047-26-006245","importance":40.006064644},{"ts":"2026-06-17","kind":"sec.insider.s","reporter":"Porter Derrell","title":null,"shares":13040,"price_per_share":2.325,"usd_value":30318,"security_title":"Common Stock","importance":35.030318},{"ts":"2026-06-17","kind":"sec.filing","form_type":"144","title":"144 — Acumen Pharmaceuticals, Inc. — 2026-06-17","url_slug":"/sec/cik-0001576885/144/0001950047-26-006245","accession_number":"0001950047-26-006245","importance":30},{"ts":"2026-06-17","kind":"sec.filing","form_type":"4","title":"4 — Acumen Pharmaceuticals, Inc. — 2026-06-17","url_slug":"/sec/cik-0001576885/4/0001628280-26-043987","accession_number":"0001628280-26-043987","importance":30},{"ts":"2026-06-17","kind":"sec.insider.m","reporter":"Porter Derrell","title":null,"shares":13040,"price_per_share":1.07,"usd_value":13953,"security_title":"Common Stock","importance":15.0139528},{"ts":"2026-06-16","kind":"sec.form144","reporter":"DERRELL PORTER","title":"Director","shares":12800,"usd_value":29768,"security_title":"Common","approx_sale_date":"2026-06-16","accession_number":"0001950047-26-006235","importance":40.005953536},{"ts":"2026-06-16","kind":"sec.insider.s","reporter":"Porter Derrell","title":null,"shares":12800,"price_per_share":2.326,"usd_value":29773,"security_title":"Common Stock","importance":35.0297728},{"ts":"2026-06-16","kind":"sec.filing","form_type":"8-K","title":"8-K — Acumen Pharmaceuticals, Inc. — 2026-06-16","url_slug":"/sec/cik-0001576885/8-k/0001628280-26-043416","accession_number":"0001628280-26-043416","importance":35},{"ts":"2026-06-16","kind":"sec.filing","form_type":"144","title":"144 — Acumen Pharmaceuticals, Inc. — 2026-06-16","url_slug":"/sec/cik-0001576885/144/0001950047-26-006235","accession_number":"0001950047-26-006235","importance":30},{"ts":"2026-06-15","kind":"sec.form144","reporter":"DERRELL PORTER","title":"Director","shares":6460,"usd_value":15149,"security_title":"Common","approx_sale_date":"2026-06-15","accession_number":"0001950047-26-006161","importance":40.00302974},{"ts":"2026-06-15","kind":"sec.insider.s","reporter":"Porter Derrell","title":null,"shares":6460,"price_per_share":2.345,"usd_value":15149,"security_title":"Common Stock","importance":35.0151487},{"ts":"2026-06-15","kind":"sec.filing","form_type":"144","title":"144 — Acumen Pharmaceuticals, Inc. — 2026-06-15","url_slug":"/sec/cik-0001576885/144/0001950047-26-006161","accession_number":"0001950047-26-006161","importance":30},{"ts":"2026-06-15","kind":"sec.insider.m","reporter":"Porter Derrell","title":null,"shares":6460,"price_per_share":1.07,"usd_value":6912,"security_title":"Common Stock","importance":15.0069122},{"ts":"2026-06-10","kind":"sec.filing","form_type":"4","title":"4 — Acumen Pharmaceuticals, Inc. — 2026-06-10","url_slug":"/sec/cik-0001576885/4/0001628280-26-042280","accession_number":"0001628280-26-042280","importance":30},{"ts":"2026-06-09","kind":"sec.form144","reporter":"NATHAN FOUNTAIN","title":"Director","shares":6400,"usd_value":14273,"security_title":"Common","approx_sale_date":"2026-06-09","accession_number":"0001950047-26-005810","importance":40.002854528},{"ts":"2026-06-09","kind":"sec.insider.s","reporter":"Fountain Nathan B","title":null,"shares":6400,"price_per_share":2.2301,"usd_value":14273,"security_title":"Common Stock","importance":35.01427264},{"ts":"2026-06-09","kind":"sec.filing","form_type":"144","title":"144 — Acumen Pharmaceuticals, Inc. — 2026-06-09","url_slug":"/sec/cik-0001576885/144/0001950047-26-005810","accession_number":"0001950047-26-005810","importance":30},{"ts":"2026-06-05","kind":"sec.filing","form_type":"4","title":"4 — Acumen Pharmaceuticals, Inc. — 2026-06-05","url_slug":"/sec/cik-0001576885/4/0001628280-26-041272","accession_number":"0001628280-26-041272","importance":30},{"ts":"2026-06-05","kind":"sec.filing","form_type":"4","title":"4 — Acumen Pharmaceuticals, Inc. — 2026-06-05","url_slug":"/sec/cik-0001576885/4/0001628280-26-041273","accession_number":"0001628280-26-041273","importance":30},{"ts":"2026-06-05","kind":"sec.filing","form_type":"4","title":"4 — Acumen Pharmaceuticals, Inc. — 2026-06-05","url_slug":"/sec/cik-0001576885/4/0001628280-26-041281","accession_number":"0001628280-26-041281","importance":30},{"ts":"2026-06-05","kind":"sec.filing","form_type":"4","title":"4 — Acumen Pharmaceuticals, Inc. — 2026-06-05","url_slug":"/sec/cik-0001576885/4/0001628280-26-041263","accession_number":"0001628280-26-041263","importance":30},{"ts":"2026-06-05","kind":"sec.filing","form_type":"4","title":"4 — Acumen Pharmaceuticals, Inc. — 2026-06-05","url_slug":"/sec/cik-0001576885/4/0001628280-26-041268","accession_number":"0001628280-26-041268","importance":30},{"ts":"2026-06-05","kind":"sec.filing","form_type":"4","title":"4 — Acumen Pharmaceuticals, Inc. — 2026-06-05","url_slug":"/sec/cik-0001576885/4/0001628280-26-041270","accession_number":"0001628280-26-041270","importance":30},{"ts":"2026-06-03","kind":"sec.filing","form_type":"8-K","title":"8-K — Acumen Pharmaceuticals, Inc. — 2026-06-03","url_slug":"/sec/cik-0001576885/8-k/0001628280-26-040447","accession_number":"0001628280-26-040447","importance":35},{"ts":"2026-06-03","kind":"sec.insider.a","reporter":"RA CAPITAL MANAGEMENT, L.P.","title":"","shares":35500,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-03","kind":"sec.insider.a","reporter":"RA Capital Healthcare Fund LP","title":"","shares":35500,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-03","kind":"sec.insider.a","reporter":"RA Capital Nexus Fund II, L.P.","title":"","shares":35500,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-03","kind":"sec.insider.a","reporter":"Kolchinsky Peter","title":"","shares":35500,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-03","kind":"sec.insider.a","reporter":"Shah Rajeev M.","title":"","shares":35500,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-03","kind":"sec.insider.a","reporter":"Drapkin Kimberlee C","title":null,"shares":35500,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-03","kind":"sec.insider.a","reporter":"Porter Derrell","title":null,"shares":35500,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-03","kind":"sec.insider.a","reporter":"Stalfort John A III","title":null,"shares":35500,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-03","kind":"sec.insider.a","reporter":"Fountain Nathan B","title":null,"shares":35500,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-03","kind":"sec.insider.a","reporter":"Stoppel Laura","title":null,"shares":35500,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-03","kind":"sec.insider.a","reporter":"Golumbeski George","title":null,"shares":35500,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-03","kind":"sec.insider.a","reporter":"Ives Jeffrey L.","title":null,"shares":35500,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-12","kind":"sec.filing","form_type":"10-Q","title":"10-Q — Acumen Pharmaceuticals, Inc. — 2026-05-12","url_slug":"/sec/cik-0001576885/10-q/0001628280-26-034204","accession_number":"0001628280-26-034204","importance":45},{"ts":"2026-05-12","kind":"sec.filing","form_type":"8-K","title":"8-K — Acumen Pharmaceuticals, Inc. — 2026-05-12","url_slug":"/sec/cik-0001576885/8-k/0001628280-26-033868","accession_number":"0001628280-26-033868","importance":35}]}